SCHEMBL4347772

SCHEMBL4347772

CCCCCC(CC(C)=O)C(CC)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.44
FFAR1 O14842 1/20 0.44
MAPT P10636 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
CA2 P00918 1/20 0.41
MAPK1 P28482 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
ALDH1A1 P00352 1/20 0.39
GRIK1 P39086 2/20 0.39
GRIK2 Q13002 2/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
CHRM1 P11229 1/20 0.38
AKR1A1 P14550 1/20 0.38
CHRM3 P20309 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27643509 0.85 GPR84 (0.50) GPR84FFAR1MAPTLCKPPARD
SCHEMBL14761700 0.85 GPR84 (0.55) GPR84FFAR1MAPTLCKPPARD
SCHEMBL8957753 0.81 CA2 (0.48) GPR84FFAR1MAPTLCKPPARD
SCHEMBL16050313 0.81 GPR84 (0.52) GPR84FFAR1MAPTLCKPPARD
SCHEMBL8658721 0.80 GPR84 (0.50) GPR84FFAR1MAPTLCKPPARD
SCHEMBL28312932 0.77 GPR84 (0.54) GPR84FFAR1MAPTLCKPPARD
SCHEMBL8356801 0.76 GPR84 (0.56) GPR84FFAR1MAPTLCKPPARD
SCHEMBL27725183 0.76 GPR84 (0.56) GPR84FFAR1MAPTLCKPPARD
SCHEMBL3042137 0.76 GPR84 (0.52) GPR84FFAR1MAPTLCKPPARD
SCHEMBL270550 0.76 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8697149-B2 Extracts and compounds from “Tulbaghia violacea” and their use as biological plant protecting agents AGRARFORUM AG (DE) 2014-04-15 US disclosed
US-20090275472-A1 EXTRACTS AND COMPOUNDS FROM \"TULBAGHIA VIOLACEA\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS AGRARFORUM AG (DE) 2009-11-05 US disclosed
EP-0211161-B1 LITHOGRAPHIC RESISTS AND METHOD OF USING THE SAME International Business Machines Corporation (US) 1990-02-28 EP disclosed
EP-0211161-A1 Lithographic resists and method of using the same International Business Machines Corporation (US) 1987-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275472-A1 EXTRACTS AND COMPOUNDS FROM \"TULBAGHIA VIOLACEA\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS GLB1, GGT1, GANC GPR84 1619/4885FFAR1 2210/4885MAPT 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.